Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics
ATXI Price/Volume Stats
| Current price | $0.21 | 52-week high | $3.93 |
| Prev. close | $0.28 | 52-week low | $0.17 |
| Day low | $0.20 | Volume | 2,300 |
| Day high | $0.24 | Avg. volume | 237,459 |
| 50-day MA | $0.24 | Dividend yield | N/A |
| 200-day MA | $1.41 | Market Cap | 662.70K |
ATXI Stock Price Chart Interactive Chart >
Avenue Therapeutics, Inc. (ATXI) Company Bio
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.
ATXI Price Returns
| 1-mo | -16.00% |
| 3-mo | -73.42% |
| 6-mo | -87.93% |
| 1-year | -94.34% |
| 3-year | -99.93% |
| 5-year | -100.00% |
| YTD | -89.50% |
| 2024 | -83.44% |
| 2023 | -86.12% |
| 2022 | -91.48% |
| 2021 | -84.74% |
| 2020 | -38.02% |
Loading social stream, please wait...